Not Rated
|
Fund Size
(0.37% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 10-Nov-25 | 10107.00 | 1.07% | - | 1.30% | 160/242 |
| 1 Month | 17-Oct-25 | 10139.60 | 1.40% | - | 1.15% | 98/235 |
| 3 Month | 14-Aug-25 | 10143.20 | 1.43% | - | 4.98% | 215/235 |
| 6 Month | 16-May-25 | 10924.50 | 9.25% | - | 6.28% | 34/225 |
| YTD | 01-Jan-25 | 10283.80 | 2.84% | - | 4.93% | 121/211 |
| 1 Year | 14-Nov-24 | 11078.70 | 10.79% | 10.69% | 7.67% | 58/198 |
| 2 Year | 17-Nov-23 | 16687.60 | 66.88% | 29.14% | 18.31% | 3/154 |
| Since Inception | 04-Oct-23 | 17633.70 | 76.34% | 30.62% | 12.97% | 3/216 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 14-Nov-24 | 12000 | 12861.02 | 7.18 % | 13.46 % |
| 2 Year | 17-Nov-23 | 24000 | 29294.7 | 22.06 % | 20.41 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 2104.3 | 10.70% | 0.23% | 13.48% (Nov 2024) | 10.39% (Aug 2025) | 12.45 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 1745.5 | 8.87% | 1.11% | 10.24% (May 2025) | 7.18% (Dec 2024) | 2.59 L | 556.00 |
| Lupin Ltd. | Pharmaceuticals | 1311.2 | 6.67% | -0.17% | 6.84% (Sep 2025) | 5.35% (Jan 2025) | 6.68 L | -0.11 L |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1189.3 | 6.05% | -0.88% | 7.42% (Jul 2025) | 2.99% (Feb 2025) | 6.29 L | -0.44 L |
| Alkem Laboratories Ltd. | Pharmaceuticals | 1147 | 5.83% | -0.11% | 5.94% (Sep 2025) | 0% (Nov 2024) | 2.08 L | 773.00 |
| Max Healthcare Institute Ltd. | Hospital | 1078.9 | 5.49% | 0.83% | 5.49% (Oct 2025) | 2.03% (Nov 2024) | 9.40 L | 1.48 L |
| Ipca Laboratories Ltd. | Pharmaceuticals | 810.1 | 4.12% | -0.38% | 4.62% (Aug 2025) | 3.26% (Jan 2025) | 6.37 L | 0.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 747 | 3.80% | 0.22% | 3.8% (Oct 2025) | 0% (Nov 2024) | 7.83 L | -0.23 L |
| Aster DM Healthcare Ltd. | Hospital | 728.9 | 3.71% | 0.16% | 3.92% (May 2025) | 3.28% (Feb 2025) | 10.75 L | 0.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 714.2 | 3.63% | -0.18% | 3.88% (Jul 2025) | 2.57% (Nov 2024) | 2.01 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.91% |
| Net Receivables | Net Receivables | -0.22% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 2.63 | 14.49 | 44.68 | 43.35 | 35.14 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | 0.96 | 2.61 | 14.67 | 29.19 | 15.26 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 4.45 | 9.70 | 18.68 | 25.31 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 1.68 | 8.32 | 17.37 | 23.55 | 12.64 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.77 | 10.08 | 18.60 | 23.12 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.94 | 7.33 | 11.43 | 22.25 | 19.79 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.67 | 9.12 | 8.59 | 21.83 | 13.64 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | 2.20 | 3.48 | 12.80 | 21.73 | 16.54 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.47 | 8.13 | 7.34 | 21.59 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.16 | 7.83 | 9.06 | 20.57 | 17.54 |
Out of 123 mutual fund schemes offered by this AMC, 4 is/are ranked 5 * , 9 is/are ranked 4 * , 16 is/are ranked 3 * , 5 is/are ranked 2 * , 1 is/are ranked 1 * , and 88 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| HDFC Balanced Advantage Fund - Growth | 4 | 106493.55 | 1.55 | 4.42 | 4.21 | 8.72 | 18.36 |
| HDFC Flexi Cap Fund - Growth | 5 | 91041.00 | 0.45 | 5.41 | 6.16 | 12.65 | 21.56 |
| HDFC Mid Cap Fund - Growth | 4 | 89383.23 | 3.65 | 7.16 | 9.82 | 12.55 | 26.56 |
| HDFC Liquid Fund - Growth | 3 | 61646.54 | 0.49 | 1.43 | 2.96 | 6.61 | 6.95 |
| HDFC Large Cap Fund - Growth | 3 | 39779.26 | 0.96 | 4.69 | 3.87 | 7.92 | 15.75 |
| HDFC Large Cap Fund - Growth | 3 | 39779.26 | 1.29 | 5.79 | 4.99 | 10.54 | 14.06 |
| HDFC Small Cap Fund - Growth | 4 | 38412.10 | 1.26 | 3.13 | 8.01 | 6.58 | 22.38 |
| HDFC Money Market Fund - Growth | 3 | 36903.78 | 0.50 | 1.51 | 3.25 | 7.49 | 7.47 |
| HDFC Corporate Bond Fund - Growth | 2 | 36133.95 | 0.28 | 1.53 | 2.38 | 7.78 | 7.80 |
| HDFC Large and Mid Cap Fund - Regular - Growth | 4 | 28486.64 | 1.44 | 5.46 | 6.28 | 9.56 | 20.64 |